条形多巴胺传播的G蛋白结合受体调节:对精神活性药物的影响的影响
Mydirah Littlepage-Saunders1,2, Michael J Hochstein1,3, Doris S Chang1,3
1Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
British journal of pharmacology
|May 31, 2023
概括
G蛋白结合受体 (GPCRs) 调节条纹体中的多巴胺释放,影响精神活性药物的作用. 了解这些GPCR机制是解释药物对行为和生理学的作用的关键.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学 是一个学科.
背景情况:
- 条形体中多巴胺的传播对于精神活性药物的奖励作用至关重要.
- G蛋白结合受体 (GPCRs) 通过各种神经调节器调节多巴胺的释放.
- 狭性多巴胺释放是由神经元发射和局部乙胆机制控制的.
研究的目的:
- 审查多巴胺转移的GPCR调制机制.
- 探索这些机制与精神活性药物效应的相关性.
主要方法:
- 对GPCRs,多巴胺和条状回路研究的文献综述.
- 分析不同的GPCR作用如何影响多巴胺释放.
- 综合与精神活性药物作用相关的发现.
主要成果:
- GPCRs通过对体质发射和局部乙胆释放的影响来调节多巴胺释放.
- 不同的GPCR机制可能会影响不同的行为方面和药物反应.
- 了解这些途径对于理解药物诱导的生理和行为变化至关重要.
结论:
- GPCRs代表调节多巴胺转移的关键目标.
- 多巴胺释放的GPCR调节差异对精神活性药物的效果有重大影响.
- 对这些机制的进一步研究可以为解决药物滥用问题的策略提供信息.
相关概念视频
G-protein Coupled Receptors
120.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.4K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
An Overview of Psychoactive Drugs
264
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
264
Drug Abuse and Addiction: Pharmacological Phenomena
574
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
574


